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Background. Mitral valve replacement can be very diﬃcult to obtain in infants because the valve annulus diameter can be smaller
than the available prosthesis. Case Report. We describe the case of a 2-month-old female weighing 3.5kg aﬀected by mitral
valve dysplasia leading to severe valve stenosis. Despite full medication, the clinical conditions were critical and surgery was
undertaken. The mitral valve was unsuitable for repair and the oriﬁce of mitral anulus was 12mm, too small for a mechanical
prosthesis. Therefore, a Ross-Kabbani operation was undertaken, replacing the mitral valve with the pulmonary autograft and
reconstructing the right ventricular outﬂow tract with an etherograft. Results. The postoperative course was uneventful and the
clinical conditions are good at 4-month follow-up. Conclusion. The Ross-Kabbani operation can be an interesting alternative to
mitral valve replacement in infants when valve repair is not achievable and there is little space for an intra-annular mechanical
prosthesis implant.
Copyright © 2009 Carlo Pace Napoleone et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Congenital mitral valve dysplasia can become symptomatic
at any age and sometimes may require surgical treatment
very early in life. Mitral valve repair is not always achievable
and the small size of the annulus can limit the possibility of
mechanical prosthesis implant. In fact, the smallest available
size of mechanical valves is 16mm. A valve prosthesis of
this size can be relatively diﬃcult to place in also if some
surgical “tricks”, like supra-annular implantation [1]c a n
help the surgeon to allow this prosthesis to ﬁt in the correct
position.Furthermore,prostheseshavenumerousdrawbacks
in infants such as the lifelong anticoagulation and the need
for reoperations for patient outgrowth.
Hence, mitral valve replacement with pulmonary auto-
graft (MVR-PA), the so-called Ross-Kabbani operation, may
represent a suitable option in case of mitral dysplasia
requiring valve replacement in infants [2].
We describe the case of a 2-month-old baby who under-
went mitral valve substitution with pulmonary autograft.
2.CaseReport
A 2-month-old female weighing 3.5kg was referred to our
centre with clinical signs of congestive heart failure. Shortly
after birth, diagnosis of ventricular septal defect (VSD)
was made. Due to failure to thrive, the baby underwent
echocardiographic evaluation that revealed a mitral valve
dysplasia compatible with hammock mitral valve with
remarkable alteration of the subvalvular apparatus leading to
severestenosis.Themeangradientacrossthemitralvalvewas
20mmHg. A 5mm perimembranous VSD was also present.
The clinical conditions were critical despite full medication
and surgery was undertaken. A mild hypothermic car-
diopulmonary bypass was established and direct inspection
after trans-septal approach conﬁrmed a very dysplastic
valve absolutely unsuitable for repair. Perimembranous VSD
was closed with bovine pericardial patch (Periguard; Bio-
Vascular Inc., St. Paul, Minn, USA). The mitral valve was
removedleavinga12mmdiameteranulusincompatiblewith
a intra-annular mechanical valve implant. The pulmonary
valve was inspected and harvested with 3mm infundibular2 Cardiology Research and Practice
Figure 1:Intraoperativeviewshowingtheperfectcontinenceofthe
autograft.
muscular rim; the pulmonary trunk was sectioned just above
the commissures. The pulmonary valve sized 10mm and
was mounted inside a 10mm long woven Dacron tube graft
of 12mm of diameter (Vascutek, Renfrewshire, Scotland).
The proximal and distal ends of the pulmonary autograft
were then secured to the Dacron graft with three Prolene
7/0 running sutures respectively (Ethicon, Somerville, NJ,
USA). The prosthesis was therefore doubly longitudinally
incised to allow autograft grow and then implanted in
the mitral anulus with 5/0 Prolene (Ethicon, Somerville,
NJ, USA) interrupted stitches secured at the distal edge.
A top-hat valve with pericardium, as recommended by
Kabbani et al. [2], Ross and Kabbani [3], was not feasible for
the small dimension of the left atrium. At the end of
the procedure, valvular continence was optimal at saline
injection (Figure 1). Right ventricular outﬂow tract was
reconstructed with a 12mm Contegra conduit (Medtronic
Inc, Minneapolis, Minn, USA). At CPB suspension, per-
sistent pulmonary hypertension was evident and inhaled
NO therapy was started and switched to oral sildenaﬁl 5
days later. The baby was discharged without complications
and after 4 months, the echocardiogram showed trivial
autograft gradient with no incompetence (Figure 2). 3D
echocardiographic evaluation conﬁrmed the good motion of
the pulmonary autograft leaﬂets.
3. Discussion
Mitral valve dysplasia is a wide spectrum of congenital mor-
phologic abnormalities that aﬀect the mitral valve resulting
in stenosis, regurgitation, or both [4]. Despite conservative
surgery always remains the ﬁrst choice, some of these lesions
can be very diﬃcult to repair, and a valvular prosthesis must
be implanted.
In infants, mitral valve replacement can be technically
demanding and an ideal valve substitute is not available as
yet. Bioprosthetic valves cannot be considered for their large
size, the high stent proﬁle, and the rapid calciﬁcation and
degeneration in the younger. Small-size mitral homografts
are not commonly available, diﬃcult to implant, and not
durable [5].
Figure 2: Postoperative echocardiograﬁc aspect of the implanted
autograft.
Mechanical prosthesis represents a valid option, even
thoughthesmallestsizeavailable,16mm,canbetoolargefor
intra-annular implant in the smaller infants. Moreover, high
early and late mortality is reported after mitral prosthesis
implantinpatientslessthanoneyearofage[6].Inparticular,
estimated survival at 10 and 15 years follow-up was 33% ±
19% and 33% ± 27% in patients less then 2-year-old
who underwent mitral valve replacement with mechanical
prosthesis [7].
Therefore, the autologous pulmonary valve may repre-
sent a valid alternative in infants with small annulus to
obviate the mismatch between the commercially available
prosthesis and the anulus of the recipient, which has been
reported to increase mortality [8].
Larger experience with Ross-Kabbani operation is
present in literature among older patients. Kabbani and
colleagues reported 80 patients with a mean age of 39.3
years treated by MVR-PA. Operative and late mortality were
respectively 5.0% and 6.25%. At a mean follow-up of 25
months, no patients underwent reoperation and most of the
surviving patients (83%) remain in class I status [2]. Authors
statedthatitisatwo-valveoperationandrequiresa“learning
curve” and it may also be considered as the best alternative
for infants and children with irreparable congenital mitral
pathology [2].
Brown and colleagues reported 8 patients between 12
and 46 years of age who underwent MVR-PA. At a mean
follow-up of 25.0 ± 6.2 months, 3 patients underwent
pulmonary autograft replacement with mechanical valves.
In two cases, progressive regurgitation was secondary to
untreated systemic hypertension causing a prolapse of a
single stretched leaﬂet of the pulmonary autograft. In the
other patient, progressive stenosis was due to preservation of
excessive native mitral leaﬂet and subannular tissue [9].
Moreover, avoidance of lifelong anticoagulation repre-
sents an invaluable beneﬁt, especially in pediatric patients,
in whom dosage management diﬃculties and side eﬀects are
particularly evident. In the cited series, oral anticoagulation
therapy was assumed for 6 to 8 weeks, in case sinus rhythm
was present [2, 9].Cardiology Research and Practice 3
Asfarasgrowpotentialisconcerned,theDacronconduit
interruption is meant to preserve the possibility to grow of
the autograft, but obviously longer follow-up is needed to
evaluate the reoperation rate in this patients [10]. Anyway,
we think that the possibility to implant a biological valve
with the best diameter-eﬀective ﬂow ratio of an adequate
dimension in a very small patient represents a valid option
regardless of the autograft growth.
There is very limited experience with the Ross Kabbani
operation in infants and at the best of our knowledge 4
patients only, less than one year of age, have been reported
in literature with a limited follow-up time [10–12].
4. Conclusions
The pulmonary autograft can be a valuable mitral valve
substitute in infants when valve repair is not achievable
and there is little space for an intra-annular mechanical
prosthesis implant. Larger numbers and longer follow-up
are indeed necessary to promote the pulmonary autograft
as mitral valve substitute of choice in patients with mitral
anulus smaller than 16mm.
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